Meclizine HCl Tablets 25 mg Recalled for Incorrect Instructions
Rising Pharmaceuticals is recalling Meclizine HCl Tablets 25 mg (Lot # CB21024, expiring 2/2023) due to incorrect labeling instructions on the packaging.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a labeling defect (incorrect instructions). The source text does not indicate any reported illnesses, injuries, or hospitalizations, and labeling errors of this type are typically classified as Moderate per the severity rubric.
Plain-English summary
Rising Pharmaceuticals is recalling Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottles (NDC 16571-752-01) due to incorrect instructions on the product labeling. The affected lot is CB21024 with an expiration date of 2/2023, distributed by Rising Pharma Holdings, Inc. in East Brunswick, NJ and manufactured by Aurex Laboratories LLC in East Windsor, NJ. A total of 1,344 bottles were distributed.
Consumers who have this product should consult the correct prescribing information or contact their healthcare provider or pharmacist for proper usage instructions. Those with questions can contact Rising Pharmaceuticals at the phone number or address provided on the product packaging.
The recalled product
- Product
- Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816, Manufactured by: Aurex laboratories LLC, East Windsor, NJ 08520, NDC 16571-752-01
- Manufacturer
- RISING PHARMACEUTICALS
- Affected units
- 1,344
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # CB21024
- Exp 2/2023
Distribution
Distribution scope not specified by the agency.
Related recalls
Same manufacturer · RISING PHARMACEUTICALS
See all →- HighWarfarin Sodium Tablets Recalled Due to Failed Impurity and Degradation Specifications
FDA (Drugs) · 2023-03-01
- ModerateMethylphenidate Hydrochloride Chewable Tablets Recalled for Failed Specifications
FDA (Drugs) · 2022-03-02
Same hazard · mis labeling
See all →- CriticalFDA Recalls Gluten-Free Veggie Chips for Undeclared Wheat
FDA (Food) · 2026-09-16
- ModerateWheel Pros Recalls 549 Avix TrailTek RT Tires for Incorrect Markings
NHTSA · 2026-09-10
- LowB Braun Recalls Discofix Stopcock Sets Due to Incorrect Expiration Date
FDA (Devices) · 2026-09-09
- HighPrince Italian Bread Recalled for Undeclared Sesame Allergen
FDA (Food) · 2026-09-09
- ModerateWonton Skin Recalled for Undeclared Red Dye
FDA (Food) · 2026-09-09